Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia

JA Charlesworth, DG Williams… - The Journal of …, 1974 - Am Soc Clin Investig
JA Charlesworth, DG Williams, E Sherington, PJ Lachmann, DK Peters
The Journal of clinical investigation, 1974Am Soc Clin Investig
Metabolic studies using radioiodine-labeled third component of complement (C3) and the
glycine-rich β glycoprotein (GBG), a major component of the C3b-feedback pathway, were
undertaken in normal subjects, in 22 patients with evidence of complement activation, and in
11 patients with various renal diseases without evidence of complement activation. In seven
normal subjects GBG was found to be a rapidly metabolized protein with catabolic rates
ranging from 1.7% to 2.2% of the plasma pool/h, synthesis rates from 0.14 to 0.21 mg/kg per …
Metabolic studies using radioiodine-labeled third component of complement (C3) and the glycine-rich β glycoprotein (GBG), a major component of the C3b-feedback pathway, were undertaken in normal subjects, in 22 patients with evidence of complement activation, and in 11 patients with various renal diseases without evidence of complement activation. In seven normal subjects GBG was found to be a rapidly metabolized protein with catabolic rates ranging from 1.7% to 2.2% of the plasma pool/h, synthesis rates from 0.14 to 0.21 mg/kg per h. and extravascular/intravascular distribution ratios from 0.81 to 1.31. In patients with reduced plasma C3, both increased C3 fractional catabolic rates and reduced C3 synthesis rates were observed, and in some patients there was evidence of increased extravascular distribution of the protein. GBG catabolism was usually increased when there was evidence of C3 activation, presumably reflecting activation of the C3b-feedback; but GBG turnover was normal or only slightly accelerated in some patients with accelerated C3 catabolism and profound hypocomplementemia, suggesting that reduced C3 synthesis had limited activation of the C3b-feedback.
Images
The Journal of Clinical Investigation